3,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)pyridazine

Catalog No. :
ACFRUU166
CAS No. :
919197-91-4
Molecular Formula :
C13H21BCl2N2O2Si
Molecular Weight :
347.13

IUPAC Name:3,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)pyridazine

3,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$302.00Login to see priceInquiryInquiry
100mg95%$442.00Login to see priceInquiryInquiry
250mg95%$623.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)pyridazine
IUPAC Name3,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)pyridazine
Molecular FormulaC13H21BCl2N2O2Si
Molecular Weight347.13
SMILESClC1=NN=C(C([Si](C)(C)C)=C1B2OC(C)(C(C)(C)O2)C)Cl
InChI KeyPUTQJCZUJGYNGB-UHFFFAOYSA-N
Synonym3,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)pyridazine;Pyridazine, 3,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trimethylsilyl)-
CAS No.919197-91-4

Synthetic Route by SureRoute

1. ACFRUU166 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRUU166 route product structure diagram
    ACFRUU166919197-91-4
Inquiry

2. ACFRUU166 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRUU166 route product structure diagram
    ACFRUU166919197-91-4
Inquiry

Comments (0)